AYTU BIOPHARMA, INC (AYTU) › Shareholders' EquityAYTU BIOPHARMA, INC (AYTU) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2005: $20.4K2006: $57.9K2007: $18.8K2008: $26.0K2009: -$13.6K2010: -$55.6K2011: -$35.6K2012: -$69.7K2013: -$110.9K2014: $5.37M2015: $15.62M2016: $10.09M2017: $4.00M2018: $13.42M2019: $7.09M2020: $95.02M2021: $137.57M2022: $44.31M2023: $39.36M2024: $27.72M2025: $18.97M$18.97M2005Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$18.97M-31.6%2024$27.72M-29.6%2023$39.36M-11.2%2022$44.31M-67.8%2021$137.57M+44.8%2020$95.02M+1240.5%2019$7.09M-47.2%2018$13.42M+235.6%2017$4.00M-60.3%2016$10.09M-35.4%2015$15.62M+190.8%2014$5.37M+4943.6%2013-$110.9K-59.0%2012-$69.7K-95.9%2011-$35.6K+36.0%2010-$55.6K-309.4%2009-$13.6K-152.3%2008$26.0K+38.0%2007$18.8K-67.5%2006$57.9K+183.7%2005$20.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share